Upload
Featured Recent Articles Topics Login Upload

Search Results for 'tumor response'

tumor response published presentations and documents on DocSlides.

Advanced Vessel- and Cell-Size MRI to Assess Chemo-Radiation Treatment Response in Pediatric Ependy
Advanced Vessel- and Cell-Size MRI to Assess Chemo-Radiation Treatment Response in Pediatric Ependy
by paisley
JS Manalo, JL Steiner, D Niemann, AM Griesinger, A...
Understanding and Exploiting the Tumor Microenvironment in
Understanding and Exploiting the Tumor Microenvironment in
by caroline
Glioblastoma. Maria Gubbiotti, MD/PhD Candidate. J...
MRI of Rectal Cancer Tumor Staging Imaging Techniques and Managemen
MRI of Rectal Cancer Tumor Staging Imaging Techniques and Managemen
by udeline
367 Rectal cancer is prone to local recurrence and...
NCI P01: Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunot
NCI P01: Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunot
by LittleMissPerfect
UW TRT . P01 . Overview. The First TRT PO1 Awarded...
Tumor agnostic approvals
Tumor agnostic approvals
by CountryBumpkin
Master trials in practice. Stat4Onc, Hartford CT. ...
Immuno-Oncology Applications
Immuno-Oncology Applications
by joy
Lee S. Schwartzberg,. MD, FACP. West Clinic, P.C....
Combining estrogen receptor blockade and radiation therapy to improve the response of breast cancer
Combining estrogen receptor blockade and radiation therapy to improve the response of breast cancer
by MommaBear
Zachary . Morris, MD/PhD. Assistant Prof. . Dept. ...
Natural History, Response to Treatment
Natural History, Response to Treatment
by lucy
Morphology,. Anatomy . Natural History, Response t...
Targeting KRAS G12C  in Solid Tumors
Targeting KRAS G12C  in Solid Tumors
by morton
: . A . New Anticancer Approach  . Marwan Fakih, ...
DRUG CONJUGATES BIND COVALENTLY TO ALBUMIN: A NEW APPROACH
DRUG CONJUGATES BIND COVALENTLY TO ALBUMIN: A NEW APPROACH
by stefany-barnette
Sant. Chawla, M.D.. Director, Sarcoma Oncology C...
Modalities in Cancer Therapy
Modalities in Cancer Therapy
by min-jolicoeur
Folder Title: . Therapy(. NoTP. ). Updated: April...
Bristol-Myers Squibb is
Bristol-Myers Squibb is
by myesha-ticknor
actively. conducting . translational . medicine. ...
To date, several case reports have demonstrated response to therapy targeting the PD1 / PD-L1 axis
To date, several case reports have demonstrated response to therapy targeting the PD1 / PD-L1 axis
by test
PD-L1 is a transmembrane protein involved in regu...
Cancer Immunotherapy and Precision
Cancer Immunotherapy and Precision
by basidell
M. edicine. . Marianna Nuti. Dipartimento di Medi...
Evaluation of the Prognostic and Predictive Significance of Hepatocellular
Evaluation of the Prognostic and Predictive Significance of Hepatocellular
by jideborn
Carcinoma Circulating Tumor Cells Expressing Progr...
Evaluating pH-sensitization of immunotherapy treatment regimens with noninvasive
Evaluating pH-sensitization of immunotherapy treatment regimens with noninvasive
by ethlyn
Chemical Exchange Saturation Transfer (CEST) MRI ....
The Management of Desmoid Tumors A joint global evidencebased consen
The Management of Desmoid Tumors A joint global evidencebased consen
by berey
The Desmoid Tumor Working Group Supported by: Sarc...
Odunsi MD PhD
Odunsi MD PhD
by caitlin
Kunle Immunotherapy in Ovarian Cancer Kunle Oduns...
Cancer and the Immune System
Cancer and the Immune System
by riley
Dr. Refif S. Al-. Shawk. . 2023. After reading th...
An APC activator (IMP321 or LAG-3Ig) combined with anti-PD
An APC activator (IMP321 or LAG-3Ig) combined with anti-PD
by yoshiko-marsland
Frédéric Triebel, M.D., PhD. , Prima Biomed Ltd...
Integration of Immunotherapy Across
Integration of Immunotherapy Across
by karlyn-bohler
the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...
Integration of Immunotherapy Across
Integration of Immunotherapy Across
by pamella-moone
the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...
The Basics of Cancer Biology
The Basics of Cancer Biology
by myesha-ticknor
Lucio Miele, M.D., Ph.D.. Part III: “The Godfat...
Consensus Statement on acromegaly
Consensus Statement on acromegaly
by stella
. therapeutic outcomes. ...
General strategies of Cancer Treatment and evaluation of Response
General strategies of Cancer Treatment and evaluation of Response
by sophia2
Lodovico Balducci M.D.. Senior Member Emeritus. Mo...
Advances in the Multidisciplinary Management of Hepatocellular Carcinoma:
Advances in the Multidisciplinary Management of Hepatocellular Carcinoma:
by Heartbreaker
Strategies for Incorporating Emerging. Immunothera...
Acromegaly therapeutic outcomes
Acromegaly therapeutic outcomes
by SchoolDaze
(Supplementary). Dr. Maryam . Dehghani. What is t...
In The Name Of GOD Individualised
In The Name Of GOD Individualised
by callie
management of . acromegaly. . SOHEILA SADEGHI. Su...
Prognostic effect of complete pathologic response following TACE on HCC patients undergoing liver r
Prognostic effect of complete pathologic response following TACE on HCC patients undergoing liver r
by emma
Woo-. Hyoung. Kang, Shin Hwang, Young-. Joo. Lee...
Sara Tolaney Capucine Baldini Alexander Spira Daniel Cho Giovanni Grig
Sara Tolaney Capucine Baldini Alexander Spira Daniel Cho Giovanni Grig
by cappi
BackgroundBackground continuedStudy DesignClinical...
Photodynamic Therapy for breast cancer
Photodynamic Therapy for breast cancer
by min-jolicoeur
Ron R. Allison, M.D.. Medical Director. 21st Cent...
M.-. van den BenttOeBraLn Tumor Center at Erasmus MC Cancer CenterRott
M.-. van den BenttOeBraLn Tumor Center at Erasmus MC Cancer CenterRott
by emily
Response assessment made OooNLnJ eas\ T1 contrast ...
Pediatric Brain Tumors: The Need for “Pristine” Biologic and Clinical Data
Pediatric Brain Tumors: The Need for “Pristine” Biologic and Clinical Data
by heartersh
Roger J. Packer, MD. Senior Vice-President Neurosc...
Response Evaluation Criteria in Solid Tumors
Response Evaluation Criteria in Solid Tumors
by karlyn-bohler
RECIST 1.1. Criteria Handout. Basic Paradigm. Ass...
Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%
Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%
by olivia-moreira
Low TPS High TPS TPS = PD-L1 tumor proportion sco...
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
by marina-yarberry
Niraparib. and . Temozolomide. in Patients with...
Personalized Cancer Therapy
Personalized Cancer Therapy
by alexa-scheidler
Immunotherapy. George Weiner, MD. Director, Holde...
Discussion Outline Cells of the Immune System
Discussion Outline Cells of the Immune System
by lois-ondreau
Innate Immunity. Receptors on T and B Cells Are S...
Innovations in Cancer Treatment
Innovations in Cancer Treatment
by jane-oiler
Stephanie Magdanz, . PharmD. , BCOP. Oncology Cli...
Identifying robust cancer treatment protocols from small experimental datasets
Identifying robust cancer treatment protocols from small experimental datasets
by aaron
Jana Gevertz, Associate Professor. Department of ...